Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA

Clinical and Vaccine Immunology

Volumn 18, Issue 4, 2011, Pages 640-646

  Qiu, Jin ^a   Yan, Lin ^a   Chen, Jianbo ^b   Chen, Crystal Y ^a   Shen, Ling ^c   Letvin, Norman L ^c   Haynes, Barton F ^d   Freitag, Nancy ^a   Rong, Lijun ^a   Frencher, James T ^a   Huang, Dan ^a   Wang, Xunming ^a   Chen, Zheng W ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Shenzhen Third Hospital   (China)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LISTERIA MONOCYTOGENES VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL IMMUNITY; BACTERIUM MUTANT; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; LISTERIOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; FEMALE; IMMUNOGLOBULIN A, SECRETORY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LISTERIA MONOCYTOGENES; LUNG; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PEPTIDE TERMINATION FACTORS; VACCINATION; VACCINES, ATTENUATED;

EID: 79954486802     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00254-10     Document Type: Article

References (32)

1. Ali, Z., et al. 2009. γδ T cell immune manipulation during chronic phase of simian HIV infection confers immunological benefits. J. Immunol. 183:5407-5417.
2. Boyer, J. D., et al. 2005. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Virology 333:88-101. (Pubitemid 40222193)
3. Brockstedt, D. G., et al. 2004. Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc. Natl. Acad. Sci. U. S. A. 101:13832-13837.
4. Brundage, R. A., G. A. Smith, A. Camilli, J. A. Theriot, and D. A. Portnoy. 1993. Expression and phosphorylation of the Listeria monocytogenes ActA protein in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 90:11890-11894.
5. Busch, D. H., I. M. Pilip, S. Vijh, and E. G. Pamer. 1998. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 8:353-362.
6. Cortes-Perez, N. G., et al. 2007. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 25:6581-6588. (Pubitemid 47224988)
7. Edelson, B. T., and E. R. Unanue. 2000. Immunity to Listeria infection. Curr. Opin. Immunol. 12:425-431.
8. Fukuyama, S., et al. 2006. Cutting edge: uniqueness of lymphoid chemokine requirement for the initiation and maturation of nasopharynx-associated lymphoid tissue organogenesis. J. Immunol. 177:4276-4280. (Pubitemid 44469755)
9. Jiang, S., et al. 2007. Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys. Vaccine 25:7470-7479. (Pubitemid 47484002)
10. Johansson, E. L., C. Bergquist, A. Edebo, C. Johansson, and A. M. Svennerholm. 2004. Comparison of different routes of vaccination for eliciting antibody responses in the human stomach. Vaccine 22:984-990.
11. Kantele, A., et al. 1998. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect. Immun. 66:5630-5635.
12. Kiyono, H., and S. Fukuyama. 2004. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat. Rev. Immunol. 4:699-710.
13. Kozlowski, P. A., S. Cu-Uvin, M. R. Neutra, and T. P. Flanigan. 1997. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 65:1387-1394.
14. Kozlowski, P. A., et al. 2002. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J. Immunol. 169:566-574. (Pubitemid 34686180)
15. Lauer, P., M. Y. Chow, M. J. Loessner, D. A. Portnoy, and R. Calendar. 2002. Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors. J. Bacteriol. 184:4177-4186. (Pubitemid 34774298)
16. Lauer, P., et al. 2008. Constitutive activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains. Infect. Immun. 76:3742-3753.
17. Lefford, M. J., S. Warner, and L. Amell. 1979. Listeria pneumonitis: influence of route of immunization on resistance to airborne infection. Infect. Immun. 25:672-679.
18. Medaglini, D., G. Pozzi, T. P. King, and V. A. Fischetti. 1995. Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc. Natl. Acad. Sci. U. S. A. 92:6868-6872.
19. Miki, K., et al. 2004. Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51. Infect. Immun. 72:2014-2021.
20. Mizuki, M., A. Nakane, K. Sekikawa, Y. I. Tagawa, and Y. Iwakura. 2002. Comparison of host resistance to primary and secondary Listeria monocytogenes infections in mice by intranasal and intravenous routes. Infect. Immun. 70:4805-4811.
21. Mullins, D. W., et al. 2003. Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. J. Exp. Med. 198:1023-1034.
22. Orr, M. T., N. N. Orgun, C. B. Wilson, and S. S. Way. 2007. Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infection. J. Immunol. 178:4731-4735.
23. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4:812-823.
24. Peters, C., E. Domann, A. Darbouche, T. Chakraborty, and M. E. Mielke. 2003. Tailoring host immune responses to Listeria by manipulation of virulence genes: the interface between innate and acquired immunity. FEMS Immunol. Med. Microbiol. 35:243-253.
25. Rayevskaya, M., N. Kushnir, and F. R. Frankel. 2002. Safety and immunogenicity in neonatal mice of a hyperattenuated Listeria vaccine directed against human immunodeficiency virus. J. Virol. 76:918-922.
26. Schoen, C., et al. 2008. Listeria monocytogenes as novel carrier system for the development of live vaccines. Int. J. Med. Microbiol. 298:45-58.
27. Shen, H., et al. 1995. Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc. Natl. Acad. Sci. U. S. A. 92:3987-3991.
28. Skoberne, M., et al. 2008. KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity. J. Clin. Invest. 118:3990-4001.
29. Stevens, R., K. E. Howard, S. Nordone, M. Burkhard, and G. A. Dean. 2004. Oral immunization with recombinant Listeria monocytogenes controls virus load after vaginal challenge with feline immunodeficiency virus. J. Virol. 78:8210-8218.
30. Thatte, J., S. Rath, and V. Bal. 1995. Analysis of immunization route-related variation in the immune response to heat-killed Salmonella typhimurium in mice. Infect. Immun. 63:99-103.
31. Weiskirch, L. M., and Y. Paterson. 1997. Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease. Immunol. Rev. 158:159-169.
32. Yan, L., et al. 2008. Selected prfA* mutations in recombinant attenuated Listeria monocytogenes strains augment expression of foreign immunogens and enhance vaccine-elicited humoral and cellular immune responses. Infect. Immun. 76:3439-3450.